Recombinant CD40-ligand Uses, Dosage, Side Effects and more

Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).

Trade Name Recombinant CD40-ligand
Generic Recombinant CD40-ligand
Recombinant CD40-ligand Other Names CD40 ligand, Recombinant CD40-ligand
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share